Dysfunction of the KCNQ2/GSK3β/PP2A-Bγ regulation pathway, and its balance, can explain changes in neuronal excitability that underline the manic and depressive episodes occurring in mood disorders (e.g., bipolar affective disorder) [210]. This evidence concerns the gene GSK3B and bipolar disorder.